Core Insights - Three companies from Suzhou have recently gone public, showcasing the city's strong industrial foundation and diverse economic landscape [1][3][6] Group 1: Recent Listings - Zhongcheng Zhixin Engineering Consulting Group Co., Ltd. was listed on the Beijing Stock Exchange on November 7, marking the third listing in Suzhou within a week [1] - The other two companies that went public are Fengbei Biotechnology on November 5 at the Shanghai Stock Exchange and Wangshan Wangshui on November 6 at the Hong Kong Stock Exchange [1] - Suzhou has added 16 new listed companies this year, with 9 of them being domestic A-share listings, ranking first in the country [1] Group 2: Company Profiles - Fengbei Biotechnology, established in 2014, specializes in the comprehensive utilization of waste oil resources and has become a leader in this field [2] - Wangshan Wangshui, founded in 2013, focuses on the discovery and commercialization of small molecule drugs, covering a full industry value chain from research to commercialization [2] - Zhongcheng Consulting, founded in 2002, is dedicated to engineering consulting and digital transformation, with services extending to countries like Vietnam and Thailand [2] Group 3: Industrial Strength - Suzhou's industrial base is robust, with a complete industrial system comprising 35 major categories and 515 subcategories, making it one of the most comprehensive industrial cities globally [5] - The city ranks first in the number of technology-based SMEs and second in the advanced manufacturing industry among Chinese cities [5] - Suzhou has a clear future industrial layout, focusing on developing eight key future industries, including advanced materials [5] Group 4: Capital Market Dynamics - The total market capitalization of Suzhou's A-share companies increased from 17,243 billion to 25,265 billion yuan, a growth of 46.5% this year [6] - The market capitalization of companies listed on the Hong Kong Stock Exchange rose from 2,685 billion HKD to 5,712 billion HKD, reflecting a 113% increase [6] - Suzhou has seen significant interest from long-term investors, with many companies receiving new investments or increased holdings due to their strong performance and growth potential [7][8]

Group 1 - The company has been deeply engaged in the comprehensive utilization of waste oil resources for over 10 years, establishing itself as a pioneer and promoter in the field [2] - The company has developed a relatively complete recycling industry chain for "waste materials" and has expanded into bio-based materials [2] - In the biofuel sector, the company has clients including TRAFIGURA and BIOSYNTECHANDELSGMBH, and as of the end of 2024, its biodiesel production capacity is expected to hold a market share of approximately 4.68% in the domestic biodiesel market [2] Group 2 - The company’s domestic market share for pesticide adjuvants is approximately 6.46% in 2023 [2] - The issuance price of the company's shares is set at 24.49 yuan, with a total market capitalization of 2.635 billion yuan [2] - The issuance price-earnings ratio is reported at 30.47 [2]

Core Viewpoint - The article discusses the recent IPOs in the A-share market, highlighting the performance of newly listed companies and upcoming IPOs, emphasizing the potential investment opportunities in the waste oil resource utilization and wind power transmission sectors. Group 1: Recent IPOs - Last week, two new stocks were listed in the A-share market: Kema Polo on the Shenzhen main board and Chaoying Electronics on the Shanghai main board, with Chaoying Electronics seeing a nearly 400% increase on its first day, yielding over 40,000 yuan in profit per subscription [1]. Group 2: Upcoming IPOs - This week (October 27 to October 31), three new stocks are set for subscription: Fengbei Biological, Delijia, and Zhongcheng Consulting, with subscriptions available on Monday and Tuesday [2]. Group 3: Fengbei Biological - Fengbei Biological's issue price is 24.49 yuan per share, with a maximum subscription limit of 11,000 shares per account, requiring a market value of 110,000 yuan in the Shanghai market for full subscription [3]. - The company is a leading player in waste oil resource utilization, focusing on producing biodiesel and bio-based materials, and has developed a comprehensive industrial chain from waste oil to biofuels [4]. - Revenue projections for 2022 to 2024 are 1.709 billion yuan, 1.728 billion yuan, and 1.948 billion yuan, with net profits of 133 million yuan, 130 million yuan, and 124 million yuan respectively [4]. Group 4: Delijia - Delijia's issue price is not specified, but the maximum subscription limit is 9,500 shares, requiring a market value of 95,000 yuan for full subscription [5]. - The company specializes in high-speed heavy-duty precision gear transmission products, primarily for wind power generation, and has established a comprehensive business chain from design to production and maintenance [5]. - Revenue projections for 2022 to 2024 are 3.108 billion yuan, 4.442 billion yuan, and 3.715 billion yuan, with net profits of 540 million yuan, 634 million yuan, and 534 million yuan respectively [6]. Group 5: Zhongcheng Consulting - Zhongcheng Consulting's issue price is 14.27 yuan per share, with a maximum subscription limit of 630,000 shares [8]. - The company provides engineering consulting services, including cost estimation and project management, and has ranked among the top in Jiangsu province for engineering cost consulting revenue from 2021 to 2024 [8]. - Revenue projections for 2022 to 2024 are 303 million yuan, 368 million yuan, and 396 million yuan, with net profits of 64 million yuan, 81 million yuan, and 105 million yuan respectively [8].

Core Insights - Fengbei Biotechnology is a pioneer in the comprehensive utilization of waste oil resources, with significant advantages in R&D, product application, and quality control [2] - The company has received numerous accolades, including being recognized as a national-level "specialized, refined, and innovative" small giant enterprise and a unicorn cultivation enterprise in Suzhou [2] - As of June 30, 2025, the company holds 135 patents, including 33 domestic invention patents and 3 international invention patents, and has obtained ISCC certification for the EU market [2] Company Highlights - Fengbei Biotechnology has established a strong customer base due to its core technological advantages, which supports the sustainable and healthy development of its business [2] - The company has been awarded the Innovation Contribution Award by the China Pesticide Association and the first prize of the China Coal Industry Science and Technology Award [2] - The company aims to provide investors with a clear understanding of its investment value and opportunities through its online roadshow [3]

Group 1: New IPOs Overview - Three new stocks are available for subscription next week, including Fengbei Biological, Zhongcheng Consulting, and Delijia [2] - Fengbei Biological has an issuance price of 24.49 CNY per share and a P/E ratio of 30.47, significantly lower than the industry average of 64.73 [4][10] - Zhongcheng Consulting has an issuance price of 14.27 CNY per share and a P/E ratio of 9.69, compared to the industry average of 40.16 [10] Group 2: Fengbei Biological - Fengbei Biological is a leading company in the comprehensive utilization of waste oil resources, focusing on a production chain from waste oil to biofuels and biobased materials [3][4] - The company reported revenues of 1.709 billion CNY in 2022, with a slight increase to 1.728 billion CNY in 2023, and projected revenues of 1.948 billion CNY for 2024 [5] - For the first half of 2025, Fengbei Biological expects revenues between 2.1 billion CNY and 2.3 billion CNY, representing a year-on-year growth of 51.40% to 65.82% [8] Group 3: Zhongcheng Consulting - Zhongcheng Consulting is an early player in the engineering consulting sector, providing comprehensive consulting services including cost estimation and project management [11] - The company has a significant reliance on clients within Jiangsu Province, with over 96% of its revenue coming from this region from 2022 to 2025 [11] - Revenue figures for Zhongcheng Consulting show a growth from 303 million CNY in 2022 to 368 million CNY in 2023, with a projected revenue of 396 million CNY for 2024 [11] Group 4: Delijia - Delijia is a leading company in the wind power industry, specializing in the research, production, and sales of precision gear transmission products [18] - The company reported revenues of 3.108 billion CNY in 2022, with a decline to 4.442 billion CNY in 2023, and a projected revenue of 3.715 billion CNY for 2024 [18] - For the first half of 2025, Delijia expects revenues between 3.938 billion CNY and 4.073 billion CNY, indicating a year-on-year growth of 61.39% to 66.92% [20]

Core Viewpoint - The IPO market is experiencing significant activity, with companies like Fengbei Bio aiming to transform waste cooking oil into valuable bio-based materials and biodiesel, marking a potential first in the A-share market for waste oil resource utilization [2][3] Company Overview - Fengbei Bio is set to raise 750 million yuan through its IPO, with a pre-IPO valuation of approximately 4 billion yuan [2][8] - The company was founded by a Fudan University graduate who was motivated by the dangers of waste cooking oil, leading to the development of various eco-friendly technologies over a decade [2][4] - Fengbei Bio has achieved a market share of 6.72% and 6.46% in agricultural pesticide and fertilizer additives, respectively [6] Market Challenges - The transformation of waste cooking oil faces three main challenges: technical difficulties, limited market demand for biodiesel, and unclear policies regarding biodiesel standards [3][6] - Despite the challenges, Fengbei Bio has managed to secure A-round financing from a prominent local venture capital firm, indicating growing interest in the green economy sector [6][8] Financial Performance - The company reported revenues of 1.709 billion yuan, 1.728 billion yuan, and 1.948 billion yuan for the years 2022, 2023, and 2024, respectively, but faced a decline in net profit [8] - The gross profit margins have also decreased, with figures of 13.55%, 13.95%, and 11.67% over the same period, indicating a challenging profitability landscape [8][9] Future Prospects - Fengbei Bio aims to utilize the IPO proceeds to enhance its production capacity and focus on new product lines, including a new annual production of 300,000 tons of fatty acid methyl esters and 50,000 tons of agricultural microbial agents [9][10] - The company’s founder holds an 85.4% stake, and a successful IPO could significantly increase his wealth, potentially exceeding 3 billion yuan [10][11]

Core Viewpoint - The company Suzhou Fengbei Biotechnology Co., Ltd. is set to undergo its initial public offering (IPO) review on August 7, 2025, marking a significant milestone in its development and showcasing its solid strength and broad prospects in the waste resource utilization industry [1] Group 1: Business Focus and Product Offerings - Since its establishment in 2014, the company has focused on the comprehensive utilization of waste oil resources, creating a complete and promising industrial chain from waste oil to biodiesel and bio-based materials [2] - The core products of the company, particularly bio-based materials, are widely used in various sectors such as pesticides, fertilizers, mining, ink resins, textiles, and biomedicine, enhancing product performance and quality [2] - The company's biodiesel serves as a strategic alternative to fossil fuels, significantly reducing carbon dioxide emissions and contributing to global energy transition [2] Group 2: Product Advantages and Market Position - The company's bio-based materials, especially in pesticide adjuvants, improve the efficacy of pesticides while reducing environmental impact, leading to better crop yield and quality [4] - In the fertilizer sector, the company's products enhance nutrient absorption and reduce waste, resulting in improved soil fertility and crop growth [4] - The biodiesel produced by the company exhibits excellent combustion performance and compatibility with traditional diesel engines, contributing to lower emissions and improved air quality [4] Group 3: Research and Development Strength - The company boasts a strong R&D team with expertise in oil chemistry, bioenergy, and materials science, driving continuous technological upgrades [6] - Collaborations with renowned universities and research institutions enhance the company's innovation capabilities and accelerate product development [7] - Significant investments in R&D have led to breakthroughs in waste oil utilization technology and bio-based material preparation, securing multiple intellectual property rights [7] Group 4: Market Opportunities and Growth Potential - The waste resource utilization industry is experiencing unprecedented growth due to increasing global focus on environmental protection and sustainable development [8] - The domestic market for waste oil resource utilization is expected to expand rapidly, driven by stringent environmental policies and support for the circular economy [8] - The demand for bio-based materials is projected to surge as industries shift towards greener alternatives, with significant growth potential in agriculture, textiles, and other sectors [8] - The market share of biodiesel is anticipated to grow as clean energy demand rises, particularly in regions with high environmental standards [8] Group 5: Competitive Advantage and Future Outlook - The company has established a significant presence in the domestic market, forming stable partnerships with numerous well-known enterprises [9] - In the context of domestic substitution, the company aims to leverage its strengths to enhance product quality and expand market share, positioning itself as a leader in the waste resource utilization industry [9]

Group 1 - The global carbon reduction policies and environmental awareness are creating new development opportunities for the waste oil resource utilization industry [1] - Suzhou Fengbei Biological Technology Co., Ltd. (Fengbei Bio) is a representative enterprise in the domestic waste oil resource utilization field, accelerating its expansion in domestic and international markets [1] - Fengbei Bio plans to issue no more than 35.9 million shares on the Shanghai Stock Exchange, with the public offering accounting for no less than 25% of the total share capital after issuance, aiming to raise 750 million yuan for various production projects [1] Group 2 - Fengbei Bio is a high-tech enterprise in the waste resource utilization sector, primarily focusing on the resource utilization of waste oil, with a secondary emphasis on oil chemical products [2] - The company is expanding the application boundaries of waste oil resource products into various industrial fields, particularly gaining a competitive advantage in the agricultural sector [2] - The capacity expansion will achieve three strategic values: breaking existing production constraints, leveraging economies of scale to reduce marginal costs, and consolidating market leadership to strengthen competitive advantages [2]